Aclaris Therapeutics, Inc.
ACRSFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Aclaris Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 13 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 8, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| ALPS ADVISORS INC | 2026-03-31 | 98,175 | $368K | SEC filing |
| Rockefeller Capital Management L.P. | 2026-03-31 | 6,112 | $22.9K | SEC filing |
| RA CAPITAL MANAGEMENT, L.P. | 2026-03-31 | 6,804,072 | $25.5M | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 486,633 | $1.7M | SEC filing |
| Assenagon Asset Management S.A. | 2026-03-31 | 177,283 | $665K | SEC filing |
| MERCER GLOBAL ADVISORS INC /ADV | 2026-03-31 | 10,595 | $39.7K | SEC filing |
| SUPERSTRING CAPITAL MANAGEMENT LP | 2026-03-31 | 366,490 | $1.37M | SEC filing |
| AQR CAPITAL MANAGEMENT LLC | 2026-03-31 | 72,408 | $272K | SEC filing |
| Farther Finance Advisors, LLC | 2026-03-31 | 347 | $1.44K | SEC filing |
| CIBC Asset Management Inc | 2026-03-31 | 17,428 | $65.4K | SEC filing |
| Vanguard Personalized Indexing Management, LLC | 2026-03-31 | 17,558 | $65.8K | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 27,300 | $102K | SEC filing |
| Balyasny Asset Management L.P. | 2026-03-31 | 3,361,328 | $12.6M | SEC filing |
| Diversified Trust Co | 2026-03-31 | 29,455 | $110K | SEC filing |
| ProShare Advisors LLC | 2026-03-31 | 18,696 | $70.1K | SEC filing |
| ALLIANCEBERNSTEIN L.P. | 2026-03-31 | 15,200 | $45.8K | SEC filing |
| MACKENZIE FINANCIAL CORP | 2026-03-31 | 213,405 | $800K | SEC filing |
| Aisling Capital Management LP | 2026-03-31 | 434,455 | $1.63M | SEC filing |
| TWO SIGMA SECURITIES, LLC | 2026-03-31 | 22,471 | $84.3K | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 379,930 | $1.42M | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Aclaris Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-11-19 · Mehra Anand: Larger than 19 of the 21 other insider purchases of Common Stock on file. SEC filing
- 2024-06-28 · Leonard Braden Michael: Larger than 20 of the 21 other insider purchases of Common Stock on file. SEC filing
- 2024-06-11 · Leonard Braden Michael: Larger than all 21 other insider purchases of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-04-23 | Leonard Braden Michael · 10% owner | Common Stock | S — Open market or private sale | −300,000 | 4.53 | SEC filing |
| 2024-11-19 | Mehra Anand · Director | Common Stock | P — Open market or private purchase | +666,666 | 2.25 | SEC filing |
| 2024-08-05 | Leonard Braden Michael · 10% owner | Common Stock | P — Open market or private purchase | +206,025 | 1.24 | SEC filing |
| 2024-08-02 | Leonard Braden Michael · 10% owner | Common Stock | P — Open market or private purchase | +167,544 | 1.29 | SEC filing |
| 2024-07-31 | Leonard Braden Michael · 10% owner | Common Stock | P — Open market or private purchase | +100,000 | 1.33 | SEC filing |
| 2024-07-30 | Leonard Braden Michael · 10% owner | Common Stock | P — Open market or private purchase | +173,730 | 1.30 | SEC filing |
| 2024-07-22 | Leonard Braden Michael · 10% owner | Common Stock | P — Open market or private purchase | +17,716 | 1.33 | SEC filing |
| 2024-07-19 | Leonard Braden Michael · 10% owner | Common Stock | P — Open market or private purchase | +6,689 | 1.30 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-05 | GOWEN MAXINE · Director | Common Stock | M — Exercise or conversion of derivative security | +11,580 | SEC filing |
| 2026-06-05 | Humphries William D. · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −11,580 | SEC filing |
| 2026-06-05 | SCHIFF ANDREW N · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −11,580 | SEC filing |
| 2026-06-05 | Molineaux Christopher P. · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −11,580 | SEC filing |
| 2026-06-05 | GOWEN MAXINE · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −11,580 | SEC filing |
| 2026-06-05 | Humphries William D. · Director | Common Stock | M — Exercise or conversion of derivative security | +11,580 | SEC filing |
| 2026-06-05 | MILANO VINCENT · Director | Common Stock | M — Exercise or conversion of derivative security | +11,580 | SEC filing |
| 2026-06-05 | Mehra Anand · Director | Common Stock | M — Exercise or conversion of derivative security | +11,580 | SEC filing |
Showing 8 of 31 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.